Related references
Note: Only part of the references are listed.Abberant inverted U-shaped brain pattern and trait-related retinal impairment in schizophrenia patients with combined auditory and visual hallucinations: a pilot study
Chuanjun Zhuo et al.
BRAIN IMAGING AND BEHAVIOR (2021)
PsyCoP - A Platform for Systematic Semi-Automated Behavioral and Cognitive Profiling Reveals Gene and Environment Dependent Impairments of Tcf4 Transgenic Mice Subjected to Social Defeat
Paul Volkmann et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2021)
Head-to-Head Comparison of Sedation and Somnolence Among 37 Antipsychotics in Schizophrenia, Bipolar Disorder, Major Depression, Autism Spectrum Disorders, Delirium, and Repurposed in COVID-19, Infectious Diseases, and Oncology From the FAERS, 2004-2020
Andy R. Eugene et al.
FRONTIERS IN PHARMACOLOGY (2021)
Bivariate genome-wide association analyses of the broad depression phenotype combined with major depressive disorder, bipolar disorder or schizophrenia reveal eight novel genetic loci for depression
Azmeraw T. Amare et al.
MOLECULAR PSYCHIATRY (2020)
An in-depth neurobehavioral characterization shows anxiety-like traits, impaired habituation behavior, and restlessness in male Cryptochrome-deficient mice
Anisja Huehne et al.
GENES BRAIN AND BEHAVIOR (2020)
Stress, Allostatic Load, and Psychosis: One Step Forward in Research But Where to Go Next?
Blazej Misiak
FRONTIERS IN PSYCHIATRY (2020)
Why is prepulse inhibition disrupted in schizophrenia?
Kohji Sato
MEDICAL HYPOTHESES (2020)
Mineralocorticoid receptor antagonist-mediated cognitive improvement in a mouse model of Alzheimer's type: possible involvement of BDNF-H2S-Nrf2 signaling
Li Chen et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2020)
Modulation of cognition and neuronal plasticity in gain- and loss-of-function mouse models of the schizophrenia risk gene Tcf4
D. M. Badowska et al.
TRANSLATIONAL PSYCHIATRY (2020)
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial
Alkomiet Hasan et al.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS (2020)
Clinical Trials and Therapeutic Rationale for Drug Repurposing in Schizophrenia
Santiago G. Lago et al.
ACS CHEMICAL NEUROSCIENCE (2019)
Mineralocorticoid receptor function and cognition in health and disease
Katja Wingenfeld et al.
PSYCHONEUROENDOCRINOLOGY (2019)
Average is good, extremes are bad - Non-linear inverted U-shaped relationship between neural mechanisms and functionality of mental features
Georg Northoff' et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Long-term Effects of Aripiprazole Treatment during Adolescence on Cognitive Function and Dopamine D2 Receptor Expression in Neurodevelopmentally Normal Rats
Hyung Jun Choi et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2019)
Genes Involved in Neurodevelopment, Neuroplasticity and Major Depression: No Association for CACNA1C, CHRNA7 and MAPK1
Marco Calabro et al.
CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE (2019)
Deconvolution of transcriptional networks identifies TCF4 as a master regulator in schizophrenia
Abolfazl Doostparast Torshizi et al.
SCIENCE ADVANCES (2019)
Cage aggression in group-housed laboratory male mice: an international data crowdsourcing project
Katie Lidster et al.
SCIENTIFIC REPORTS (2019)
Oligodendrocytes as A New Therapeutic Target in Schizophrenia: From Histopathological Findings to Neuron-Oligodendrocyte Interaction
Florian J. Raabe et al.
CELLS (2019)
Assessing behavior and cognition in rodents, nonhuman primates, and humans: where are the limits of translation?
Marius Stephan et al.
DIALOGUES IN CLINICAL NEUROSCIENCE (2019)
Mouse Phenome Database: an integrative database and analysis suite for curated empirical phenotype data from laboratory mice
Molly A. Bogue et al.
NUCLEIC ACIDS RESEARCH (2018)
The Psychiatric Risk Gene Transcription Factor 4 (TCF4) Regulates Neurodevelopmental Pathways Associated With Schizophrenia, Autism, and Intellectual Disability
Marc P. Forrest et al.
SCHIZOPHRENIA BULLETIN (2018)
Prenatal inflammation and risk for schizophrenia: A role for immune proteins in neurodevelopment
Dana M. Allswede et al.
DEVELOPMENT AND PSYCHOPATHOLOGY (2018)
Aripiprazole-induced adverse metabolic alterations in polyl:C neurodevelopmental model of schizophrenia in rats
Katerina Horska et al.
NEUROPHARMACOLOGY (2017)
Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice
Yuta Hara et al.
PSYCHOPHARMACOLOGY (2017)
Future of Days Past: Neurodevelopment and Schizophrenia
Daniel R. Weinberger
SCHIZOPHRENIA BULLETIN (2017)
Chronic atypical antipsychotics, but not haloperidol, increase neurogenesis in the hippocampus of adult mouse
Koji Chikama et al.
BRAIN RESEARCH (2017)
Animal models in psychiatric research: The RDoC system as a new framework for endophenotype-oriented translational neuroscience
Elmira Anderzhanova et al.
NEUROBIOLOGY OF STRESS (2017)
Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice
Michael C. Wehr et al.
EMBO MOLECULAR MEDICINE (2017)
Interactions of genetic variants reveal inverse modulation patterns of dopamine system on brain gray matter volume and resting-state functional connectivity in healthy young adults
Jiayuan Xu et al.
BRAIN STRUCTURE & FUNCTION (2016)
Molecular Signatures of Psychosocial Stress and Cognition Are Modulated by Chronic Lithium Treatment
Magdalena M. Brzozka et al.
SCHIZOPHRENIA BULLETIN (2016)
From neuroleptics to neuroscience and from Pavlov to psychotherapy: more than just the emperor's new treatments for mental illnesses?
Juergen Margraf et al.
EMBO MOLECULAR MEDICINE (2016)
Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study
Tiffany A. Greenwood et al.
SCHIZOPHRENIA RESEARCH (2016)
Drug repurposing and emerging adjunctive treatments for schizophrenia
Jan Malte Bumb et al.
EXPERT OPINION ON PHARMACOTHERAPY (2015)
Dopaminergic modulation of locomotor network activity in the neonatal mouse spinal cord
Simon A. Sharples et al.
JOURNAL OF NEUROPHYSIOLOGY (2015)
Kraepelin revisited: schizophrenia from degeneration to failed regeneration
P. Falkai et al.
MOLECULAR PSYCHIATRY (2015)
Effects of genetic variations in NRG1 on cognitive domains in patients with schizophrenia and healthy individuals
Youngah Cho et al.
PSYCHIATRIC GENETICS (2015)
Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain
Chao Deng et al.
PSYCHIATRY RESEARCH (2015)
Arguments for the Sake of Endophenotypes: Examining Common Misconceptions About the Use of Endophenotypes in Psychiatric Genetics
David C. Glahn et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2014)
Influence of Aripiprazole, Risperidone, and Amisulpride on Sensory and Sensorimotor Gating in Healthy 'Low and High Gating' Humans and Relation to Psychometry
Philipp A. Csomor et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Phenotypic effects of repeated psychosocial stress during adolescence in mice mutant for the schizophrenia risk gene neuregulin-1: A putative model of gene x environment interaction
Lieve Desbonnet et al.
BRAIN BEHAVIOR AND IMMUNITY (2012)
Transgenic Overexpression of the Type I Isoform of Neuregulin 1 Affects Working Memory and Hippocampal Oscillations but not Long-term Potentiation
Inga H. Deakin et al.
CEREBRAL CORTEX (2012)
Development of Hyperactivity and Anxiety Responses in Dopamine Transporter-Deficient Mice
Alex C. Carpenter et al.
DEVELOPMENTAL NEUROSCIENCE (2012)
Improvement of cognitive impairment in female type 2 diabetes mellitus mice by spironolactone
Akiko Sakata et al.
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2012)
Schizophrenia risk polymorphisms in the TCF4 gene interact with smoking in the modulation of auditory sensory gating
Boris B. Quednow et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Neurobehavioral and genotoxic parameters of antipsychotic agent aripiprazole in mice
Jaqueline Nascimento Picada et al.
ACTA PHARMACOLOGICA SINICA (2011)
Acute treatment with cannabinoid receptor agonist WIN55212.2 improves prepulse inhibition in psychosocially stressed mice
Magdalena M. Brzozka et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The Schizophrenia Risk Allele C of the TCF4 rs9960767 Polymorphism Disrupts Sensorimotor Gating in Schizophrenia Spectrum and Healthy Volunteers
Boris B. Quednow et al.
JOURNAL OF NEUROSCIENCE (2011)
Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis
M. J. Green et al.
MOLECULAR PSYCHIATRY (2011)
A Randomized Trial on Mineralocorticoid Receptor Blockade in Men: Effects on Stress Responses, Selective Attention, and Memory
Sandra Cornelisse et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats
Kinga Burda et al.
PHARMACOLOGICAL REPORTS (2011)
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Richard B. Mailman et al.
CURRENT PHARMACEUTICAL DESIGN (2010)
Taming anxiety in laboratory mice
Jane L. Hurst et al.
NATURE METHODS (2010)
Animal models of neuropsychiatric disorders
Eric J. Nestler et al.
NATURE NEUROSCIENCE (2010)
Effects of aripiprazole on MK-801-induced prepulse inhibition deficits and mitogen-activated protein kinase signal transduction pathway
Daisuke Ishii et al.
NEUROSCIENCE LETTERS (2010)
Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice
Inga H. Deakin et al.
NEUROREPORT (2009)
Aripiprazole, an atypical antipsychotic prevents the motor hyperactivity induced by psychotomimetics, and psyphostimulants in mice
Juliana V. Leite et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2008)
Dose translation from animal to human studies revisited
Shannon Reagan-Shaw et al.
FASEB JOURNAL (2008)
The atypical antipsychotic, aripiprazole, blocks phencyclidine-induced disruption of prepulse inhibition in mice
Kim Fejgin et al.
PSYCHOPHARMACOLOGY (2007)
Further evidence for association between ErbB4 and schizophrenia and influence on cognitive intermediate phenotypes in healthy controls
K. K. Nicodemus et al.
MOLECULAR PSYCHIATRY (2006)
Dissociation between in vivo occupancy and functional antagonism of dopamine D2 receptors:: Comparing aripiprazole to other antipsychotics in animal models
Sridhar Natesan et al.
NEUROPSYCHOPHARMACOLOGY (2006)
The involvement of ErbB4 with schizophrenia:: Association and expression studies
G Silberberg et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2006)
Food intake, water intake, and drinking spout side preference of 28 mouse strains
AA Bachmanov et al.
BEHAVIOR GENETICS (2002)
Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter
RR Gainetdinov et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
